Fevisafe 400 Tablet contains Favipiravir 400mg, an antiviral medication primarily used to treat viral infections such as influenza and certain emerging viral diseases. Favipiravir works by inhibiting the RNA-dependent RNA polymerase enzyme, which is essential for viral replication, thereby preventing the virus from multiplying and spreading within the body. This medication is often prescribed for managing mild to moderate cases of viral infections and is particularly useful in controlling outbreaks by reducing the viral load. Fevisafe 400 is typically administered orally, with dosage and duration determined by the severity of the infection and the patient’s clinical condition. It is important to follow the prescribed regimen strictly to achieve optimal therapeutic outcomes. Common side effects may include mild gastrointestinal discomfort, elevated liver enzymes, and transient increases in uric acid levels, but serious adverse reactions are rare when used appropriately. Fevisafe 400 should be used under medical supervision, especially in patients with pre-existing liver or kidney conditions, and is not recommended during pregnancy due to potential teratogenic effects. Patients are advised to inform their healthcare provider about any other medications they are taking to avoid drug interactions. Overall, Fevisafe 400 Tablet is an effective antiviral agent that helps in the management and control of specific viral infections.